Phase Ib and Phase II Studies of anti-PD-1 Antibody MK-3

  • Rao, Arpit (PI)
  • Gupta, Shilpa (Prior Principal Investigator)

Project: Research project

Project Details

Description

Phase Ib and Phase II Studies of anti-PD-1 Antibody MK-3475 in Combination with Bevacizumab for the Treatment of Metastatic renal Cell Carcinoma: Big Ten Cancer Research Consortium BTCRC-GU14-003
StatusActive
Effective start/end date8/1/15 → 12/31/20

Funding

  • HOOSIER CANCER RESEARCH NETWORK, INC.
View all
View less

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.